Revolution Medicines, Inc.RVMDNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-689.52M
↓ 197% below average
Average (7y)
$-232.41M
Historical baseline
Range
High:$-31.13M
Low:$-689.52M
CAGR
+55.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-689.52M | -41.5% |
| 2023 | $-487.19M | -88.6% |
| 2022 | $-258.28M | -37.4% |
| 2021 | $-188.01M | -69.8% |
| 2020 | $-110.70M | -104.5% |
| 2019 | $-54.12M | -34.2% |
| 2018 | $-40.33M | -29.6% |
| 2017 | $-31.13M | - |